3/12/2013

Biopharmaceutical companies are developing 907 biologic drugs and vaccines for more than 100 diseases, according to a PhRMA report. The lineup includes 134 vaccines for infectious diseases, 338 oncology drugs, 71 treatments that target autoimmune diseases and 58 for cardiovascular conditions.

Related Summaries